CIPLA PAIN RELIEF ASPIRIN 300mg dispersible tablet blister pack

Main information

  • Trade name:
  • CIPLA PAIN RELIEF ASPIRIN 300mg dispersible tablet blister pack
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CIPLA PAIN RELIEF ASPIRIN 300mg dispersible tablet blister pack
    Australia
  • Language:
  • English

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization status:
  • Registered
  • Authorization number:
  • 196000
  • Last update:
  • 21-05-2019

Public Assessment Report

Public Summary

Summary for ARTG Entry:

196000

CIPLA PAIN RELIEF ASPIRIN 300mg dispersible tablet blister pack

ARTG entry for

Medicine Registered

Sponsor

Cipla Australia Pty Ltd

Postal Address

Level 1 / 132-136 Albert Road,SOUTH MELBOURNE, VIC, 3205

Australia

ARTG Start Date

23/03/2012

Product category

Medicine

Status

Active

Approval area

Non-Prescription Medicines

Conditions

Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods

Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered

or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Products

1. CIPLA PAIN RELIEF ASPIRIN 300mg dispersible tablet blister pack

Product Type

Single Medicine Product

Effective date

7/10/2015

Warnings

No Warnings included on Record

Standard Indications

Specific Indications

For the temporary relief from pain associated with headaches and migraine headaches, rheumatic and arthritic pain, fibrositis, neuralgia, toothache, cold

and flu symptoms, sore throats and period pain . Relieves inflammation associated with back and muscular pain, strains and sprains. Reduces fever.

Additional Product information

Container information

Type

Material

Life Time

Temperature

Closure

Conditions

Strip Pack

Al/Al

36 Months

Store below 25

degrees Celsius

Not recorded

Not recorded

Pack Size/Poison information

Pack Size

Poison Schedule

Not scheduled. Not considered by committee

Components

1.

Dosage Form

Tablet, uncoated

Route of Administration

Oral

Visual Identification

White uncoated circular biconvex tablets, wth deep score on one side and

plain on other side

Active Ingredients

Aspirin

300 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 28.11.2017 at 03:15:09 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information